Market capitalization | €94.99m |
Enterprise Value | €97.34m |
P/E (TTM) P/E ratio | 22.22 |
EV/FCF (TTM) EV/FCF | 72.10 |
EV/Sales (TTM) EV/Sales | 2.33 |
P/S ratio (TTM) P/S ratio | 2.27 |
P/B ratio (TTM) P/B ratio | 5.65 |
Revenue growth (TTM) Revenue growth | 41.59% |
Revenue (TTM) Revenue | €41.78m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast Limes Schlosskliniken:
1 Analyst has issued a forecast Limes Schlosskliniken:
Jun '24 |
+/-
%
|
||
Revenue | 42 42 |
42%
42%
|
|
Gross Profit | 16 16 |
53%
53%
|
|
EBITDA | 8.31 8.31 |
12%
12%
|
EBIT (Operating Income) EBIT | 5.44 5.44 |
13%
13%
|
Net Profit | 4.27 4.27 |
32%
32%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Limes Schlosskliniken AG engages in the operation of clinics and healthcare facilities. The firm provides medical and diagnostic services in the fields of psychiatry, psychotherapy, and psychosomatic medicine. It also offers psychological assessment, psychiatric treatment and therapy, awareness and breathing exercises, meditation, yoga, personal training, acupuncture, ergotherapy, as well as nutrition counselling. The company was founded by Gert Michael Frank on December 1, 2005 and is headquartered in Cologne, Germany.
Head office | Germany |
CEO | Gert Frank |
Employees | 207 |
Founded | 2005 |
Website | www.limes-schlosskliniken.de |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.